Study ID: PM034
Study Title
- Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients
Teva Identifier
- PM034
ClinicalTrials.gov Identifier
- NCT01167426
Study Status
- Completed
Trial Condition(s)
- Multiple Sclerosis
Interventions
- Drug: Glatiramer Acetate 20 mg/0.5 mL | Drug: Glatiramer acetate 20 mg/0.5 mL
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years and older
Trial Duration
- 07/01/2010 - 12/01/2010
Phase
- Phase 3
Study Type
Interventional
